Midi Health Reviews and Complaints: Is It Actually Legit?
Yes, Midi Health is a real, licensed telehealth company that bills insurance for menopause care. Its record has some rough spots, mostly insurance-billing complaints, and they are worth knowing before you book.
Medically reviewed by Jill Garnier, MDA menopause-specialist telehealth service that bills insurance. Midi is in-network with most PPO plans, so a specialist visit often costs just your copay. It also sells compounded GLP-1s for midlife weight, including a dual-action GLP-1/GIP option dosed like tirzepatide, though not sold under that name.
What you will actually pay
We may earn a commission if you sign up through a link. It never affects the ranking. How we review
PPO-insured women; Midi is in-network with most PPO plans
Get startedUninsured, out-of-network, or Medicare patients
Get startedSingle-mechanism GLP-1 weight management integrated with midlife hormonal care
Get startedWomen who want the dual-mechanism option; not sold under the tirzepatide name but tracks the same dosing tiers
Get startedEstimated all-in cost: HRT: about $700 a year self-pay for a first visit and 3 follow-ups, or your copays if in-network · Medicine extra · GLP-1 medicine, first year on label dose steps: about $3,300–$4,150 single-action, about $3,650–$5,100 dual-action · Visits extra
- ✓ In-network with most PPO plans, so an HRT visit usually costs your specialist copay
- ✓ HSA and FSA cards accepted for visits and services
- ✓ Clinicians are trained specifically in perimenopause and menopause care
- ✓ Addresses both hormonal and metabolic midlife health in one platform
- ✓ Compounded GLP-1s from about $165 every four weeks, or about $210 for the dual-action GLP-1/GIP, with shipping included and no membership
- ✓ Evidence-based HRT prescribing approach rather than symptom minimization
- ✓ Accessible for women who have felt dismissed by primary care providers
- ⚑ Washington, DC isn't named among Midi's service areas, even though it advertises all 50 states
- ⚑ Labs and prescriptions are billed separately from visits
- ⚑ Out-of-network and uninsured patients pay $250 for the first visit and $150 per follow-up; Medicaid and Medi-Cal patients cannot be seen
- ⚑ Compounded GLP-1 medicine is self-pay only, and visits are billed on top of the GLP-1 price
- ⚑ Compounded GLP-1s are not FDA-approved, and the FDA does not review them for safety or quality before sale
- ⚑ No brand-name GLP-1 at a set price: the dual-action option is compounded, and brand-name GLP-1s go to your own pharmacy at your plan's price
Is Midi Health legit, or a scam?
Midi Health is a real company, not a scam. It was founded in 2021 and is based in Palo Alto, California.
Serious investors have checked it out more than once. Midi has raised about $250 million over several funding rounds. Its latest round, in February 2026, valued the company at over $1 billion.
Backers include Goodwater Capital, GV, Emerson Collective and Serena Ventures. Celebrity investors such as Tory Burch and Amy Schumer joined an earlier round. A shell operation doesn't attract that kind of repeated scrutiny.
Midi's clinicians are licensed, and it advertises care in all 50 states. It bills major insurers directly for menopause visits. It has also been BBB accredited since March 2024.
A real company can still frustrate real patients. The sections below cover the complaints, lawsuits and rules worth knowing before you share your insurance card or your credit card.
What do Midi Health reviews and complaints say?
Midi holds a B rating from the Better Business Bureau, per its BBB.org profile. A B is a middling grade. It sits well above the F that some online weight-loss brands carry.
The profile lists 176 complaints closed in the last three years. That is a meaningful number to weigh, even for a fast-growing company.
On Trustpilot, Midi scores about 4.1 out of 5 from nearly 1,700 reviews. Most reviewers are happy with their care. The unhappy ones mostly repeat the billing and delay complaints seen on BBB.
Reading both sites together gives a fairer picture than either one alone.
What are the most common Midi Health complaints?
- Insurance billing surprises: patients say they were told a visit was in-network, then got a self-pay bill. This is the top theme on BBB and Trustpilot. It matters most for a company built on insurance.
- Slow prescriptions and replies: some patients waited weeks for a medicine or a refill. They also describe slow answers from support.
- Unclear care decisions: a smaller group felt a dose or medicine change wasn't explained well.
- Labs cost extra: Midi's clinicians can order blood tests when needed, but labs are billed separately from your visit. Your insurance may cover some or all of that cost.
- Washington, DC isn't named: Midi advertises all 50 states, but its site doesn't list DC. DC residents should check at sign-up.
- Weight medicine is self-pay: insurance can cover hormone therapy visits. It does not cover Midi's compounded GLP-1 weight medicine, and visits are billed on top of the medicine price.
Has Midi Health been sued?
Yes, twice. The people who filed both cases dropped them, and neither ended in a ruling against Midi.
Both were proposed class actions in federal court in Northern California. Both claimed that tracking code on joinmidi.com shared visitors' health information with tech companies without consent.
In the first case, N.C. v. Midi Health, Inc., two patients sued in March 2025. They named Meta, Google and TikTok among the companies that received the data. They dropped the case in September 2025, before Midi had filed an answer.
In the second, Baker v. Midi Health, Inc., one woman sued in December 2025 over Google and TikTok tracking. She dropped the case in March 2026.
A dropped case proves nothing either way. The public dockets show no settlement terms and no finding against Midi.
Midi was not part of the 2025 Eli Lilly lawsuit wave. In April 2025, Lilly sued four telehealth companies over compounded tirzepatide: Henry Meds, Mochi Health, Willow Health and Fella Health. Midi was not among them, per CNBC and NPR.
Midi also dropped an ad claim in February 2026. The National Advertising Division, an industry watchdog run by BBB National Programs, questioned one of its Instagram posts. The post invited women to "join the 91% of patients who find relief within 2 months."
Midi told the watchdog it had permanently stopped using the claim, per the published decision. So the claim was never tested on its merits. That is not a lawsuit, but it does show Midi pulling a result claim rather than defending it.
Has the FDA taken action against Midi Health?
No. We found no FDA warning letter to Midi Health or joinmidi.com in the FDA's public warning-letter database. A warning letter is the FDA's formal notice that a company broke the rules.
The FDA has sent many such letters to compounded GLP-1 sellers since 2025. None that we found was addressed to Midi.
No warning letter is not an FDA stamp of approval. It simply means Midi has not been cited the way several compounded GLP-1 sellers have.
Are Midi Health's clinicians real menopause specialists?
Midi says all its clinicians are board-certified, meaning they passed a national exam in their field. Its clinician page counts more than 550 of them.
Your visits are with a nurse practitioner or a certified nurse midwife. Both are advanced-practice nurses who can diagnose and prescribe.
Midi says its clinicians specialize in women's health and train continuously in perimenopause and menopause care. Their care plans follow protocols written by Midi's physicians and clinical advisors.
That menopause focus is what sets Midi apart from general telehealth apps, where menopause is a side offering. No public registry shows each clinician's training. You can ask yours about her menopause background at your first visit.
Is Midi Health's compounded GLP-1 program in a regulatory gray area?
Somewhat, but no more than any compounded GLP-1 program. Compounded means a pharmacy mixes the medicine for one patient's prescription. It is legal, but the product is not FDA-approved.
Midi sells a GLP-1 and a dual-action GLP-1/GIP medicine for midlife weight. GLP-1 drugs curb appetite and slow digestion. Midi says its partner pharmacies are licensed and 503A-accredited, per its GLP-1 pricing page.
A 503A pharmacy makes medicine for individual prescriptions. It is overseen mainly by state pharmacy boards, not by FDA product approval.
The rules have tightened. Tirzepatide came off the FDA shortage list in late 2024, and semaglutide followed in early 2025. Since then, pharmacies may compound them only for a real individual need, not as mass copies.
On April 30, 2026, the FDA also proposed keeping semaglutide, tirzepatide and liraglutide off the 503B bulks list. That list covers large outsourcing facilities, not the 503A pharmacies Midi uses.
The FDA extended the comment period, which closed on July 30, 2026. No final decision had been issued as of September 30, 2026.
So Midi's weight program stands on shakier ground than its hormone care, which mostly uses FDA-approved hormones. Prices and supply for compounded GLP-1s could change. The Midi Health cost guide has current GLP-1 prices.
Is your health data safe with Midi?
Midi's privacy notice says it follows HIPAA, the federal law that protects your medical records. The notice also says Midi must tell you within 60 days if your health data is breached.
The two lawsuits above were about website tracking code, not a hack. Both were dropped, and no court ruled on the claims.
We found no action against Midi by the Federal Trade Commission, the agency that polices health-app privacy.
Midi's terms and conditions include binding arbitration. That means a dispute over your bill or your data goes to a private arbitrator, not a court. You also give up the right to join a class action.
You can opt out. Mail Midi a written opt-out within 30 days of first accepting its terms. The mailing address is in the arbitration section of the terms.
What does Reddit say about Midi Health?
Midi comes up in r/Menopause threads. Some women there praise feeling heard after years of being brushed off by other doctors.
If you search there, trust detailed posts over one-line verdicts. The useful ones give dates, what was billed and what the clinician actually said.
Red flags to check before you enroll
- Check your coverage first: enter your state and insurer on Midi's insurance page, then call your insurer to confirm Midi is in-network for your plan. Most billing complaints start here.
- Ask about training: ask your clinician about her menopause training at your first visit.
- Ask about the pharmacy: for the compounded GLP-1, ask which 503A pharmacy fills it. Then check that its state license is current.
- Read the cancellation terms: do it before you enter a card number. Screenshot any cancellation confirmation.
- Decide on arbitration: if you want to keep your right to sue, mail the opt-out within 30 days.
- Live in Washington, DC? Confirm coverage at sign-up, since Midi's site doesn't name DC.
- Read more than one rating: BBB, Trustpilot and the ad-watchdog decision each show a different piece of the story.
The bottom line: is Midi Health legit?
Yes. Midi Health is a legitimate, well-funded telehealth company with licensed clinicians and real insurance billing. It was not part of Eli Lilly's 2025 lawsuits against compounded GLP-1 sellers.
Its record has a few rough spots. Two privacy lawsuits were filed and then dropped. It pulled an ad claim rather than defend it. Its B rating mostly reflects billing complaints.
None of that says stay away. It says confirm your coverage before your first visit, ask about your clinician's training, and read the terms.
Frequently asked questions
Does Midi Health accept insurance?+–
Yes. Midi is in-network with most PPO plans, and names carriers such as Aetna, Blue Cross Blue Shield, Cigna and UnitedHealthcare. In-network, you usually pay your specialist copay plus any deductible left on your plan. Medicare is out of network, and Midi can't accept Medicaid or Medi-Cal patients right now.
What does Midi Health cost without insurance?+–
Self-pay visits cost $250 for the first one and $150 for each follow-up. There is no membership fee. Compounded GLP-1s cost extra, from about $165 every four weeks, or about $210 for the dual-action GLP-1/GIP option.
What menopause treatments does Midi Health offer?+–
Midi focuses on hormone therapy for perimenopause and menopause. It uses FDA-approved hormones by default, as pills, patches, rings or creams. Its clinicians can also prescribe non-hormonal treatments. A separate weight program offers compounded GLP-1s.
Does Midi Health include lab work?+–
No. Midi's clinicians can order labs when needed, but labs are billed separately from your visit. Your insurance may cover some or all of the cost.
Is Midi Health available in my state?+–
Yes, in all 50 states. Midi offers virtual visits and prescriptions nationwide. Washington, DC isn't named on its site, so DC residents should check at sign-up.
How does Midi's GLP-1 program work for menopause?+–
Midi offers two compounded options. The single-action GLP-1 starts at about $165 every four weeks. The dual-action GLP-1/GIP starts at about $210. Menopause-trained clinicians manage it alongside hormone care. The medicine is self-pay, and visits are billed separately.
Are Midi Health providers menopause specialists?+–
Midi trains its clinicians specifically in perimenopause and menopause care. The team includes physicians and nurse practitioners. That focus sets it apart from general telehealth services, where menopause is a side offering.
Is there a Midi Health coupon code?+–
Not for visits or the GLP-1 program. The codes you see online are for Midi's supplement store, which gives 10% off when you join its email list. With a PPO plan, your insurance is the bigger discount. Our Midi Health coupon page explains every way to pay less.